X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (7) 7
cancer (5) 5
chemotherapy (4) 4
gemcitabine (4) 4
index medicus (4) 4
life sciences (4) 4
folfirinox (3) 3
humans (3) 3
multivariate analysis (3) 3
prognosis (3) 3
quality-of-life (3) 3
[ sdv.can ] life sciences [q-bio]/cancer (2) 2
adenocarcinoma (2) 2
aged (2) 2
analysis (2) 2
diagnosis tripod (2) 2
enterocolitis (2) 2
female (2) 2
individual prognosis (2) 2
male (2) 2
middle aged (2) 2
palliative chemotherapy (2) 2
pancreatic cancer (2) 2
pancreatic neoplasms - mortality (2) 2
pancreatic neoplasms - pathology (2) 2
proportional hazards models (2) 2
therapy (2) 2
advanced pancreatic carcinoma (1) 1
age factors (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
ascites - etiology (1) 1
biliary stents (1) 1
biliary tract (1) 1
biliary tract cancer (1) 1
biliary-tract cancer (1) 1
biomarker (1) 1
bleeding (1) 1
breast-cancer (1) 1
calibration (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - analogs & derivatives (1) 1
cancer pain - etiology (1) 1
cancer patients (1) 1
carcinoma, pancreatic ductal - diagnosis (1) 1
carcinoma, pancreatic ductal - drug therapy (1) 1
carcinoma, pancreatic ductal - economics (1) 1
carcinoma, pancreatic ductal - mortality (1) 1
carcinoma, pancreatic ductal - secondary (1) 1
carcinoma, pancreatic ductal - therapy (1) 1
care and treatment (1) 1
chemoradiotherapy (1) 1
cholangiocarcinoma (1) 1
cirrhosis (1) 1
cisplatin (1) 1
clinical parameters (1) 1
clinical study (1) 1
cohort studies (1) 1
combination (1) 1
computed tomography (1) 1
confidence intervals (1) 1
conko-study-group (1) 1
cost analysis (1) 1
cost effectiveness (1) 1
cost-benefit analysis (1) 1
cost-effectiveness analysis (1) 1
cost-utility analyses (1) 1
cost-utility analysis (1) 1
deaths (1) 1
decision analysis (1) 1
decision making (1) 1
decision-analysis (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
diarrhea (1) 1
disease-free survival (1) 1
docetaxel (1) 1
economic evaluation (1) 1
endoscopic ultrasound (1) 1
evaluation (1) 1
failure (1) 1
fibroblast growth factor receptor (1) 1
fluorouracil - administration & dosage (1) 1
folinic acid (1) 1
head adenocarcinoma (1) 1
health aspects (1) 1
health care (1) 1
health care costs (1) 1
health status (1) 1
human health and pathology (1) 1
identification methods (1) 1
immune cells (1) 1
isocitrate dehydrogenase (1) 1
jaundice - etiology (1) 1
laboratory parameters (1) 1
leukemia (1) 1
liver neoplasms - secondary (1) 1
locally advanced pancreatic cancer (1) 1
lymphocyte ratio (1) 1
mathematical models (1) 1
medical and health sciences (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Cancer, ISSN 0959-8049, 04/2019, Volume 111, pp. 94 - 106
Journal Article
Oncotarget, ISSN 1949-2553, 05/2018, Volume 9, Issue 39, pp. 25617 - 25629
The FOLFIRINOX regimen is the standard first-line treatment for advanced pancreatic adenocarcinoma (aPDAC). However, because of its potential toxicity,... 
Biomarker | FOLFIRINOX | Advanced pancreatic carcinoma | Splenic volume | Life Sciences | Cancer
Journal Article
Cancers, ISSN 2072-6694, 12/2019, Volume 12, Issue 1, p. 77
Hepatocellular carcinoma (HCC) and biliary tract cancers (BTC) display a poor prognosis with 5-year overall survival rates around 15%, all stages taken... 
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2017, Volume 86, p. 207
Objectives The economic evaluation (EE) of healthcare interventions has become a necessity. However, high quality needs to be ensured in order to achieve... 
Health care | Adenocarcinoma | Evaluation | Decision making | Identification methods | Quality of life | Reviews | Cost effectiveness | Pancreatic cancer | Quality control | Quality assessment | Cost analysis | Pancreas
Journal Article
Anticancer Research, ISSN 0250-7005, 04/2018, Volume 38, Issue 4, p. 2443
Background: Enterocolitis is a rare, but serious gastrointestinal complication associated with docetaxel-based chemotherapy in patients with cancer. The... 
Mucositis | Diarrhea | Medical records | Risk reduction | Nausea | Enterocolitis | Multivariate analysis | Risk analysis | Patients | Bleeding | Confidence intervals | Chemotherapy | Computed tomography | Vomiting | Rectum | Cancer | Neutropenia
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 10/2017, Volume 109, Issue 10
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4_suppl, pp. 354 - 354
354 Background: In advanced pancreatic ductal adenocarcinoma (aPDAC), there is no consensual strategy for second-line chemotherapy (L2). Better discrimination... 
Journal Article
Anticancer Research, ISSN 0250-7005, 04/2018, Volume 38, Issue 4, pp. 2443 - 2446
Background: Enterocolitis is a rare, but serious gastrointestinal complication associated with docetaxel-based chemotherapy in patients with cancer. The... 
Chemotherapy | Typhlitis | Enterocolitis | Docetaxel | Cancer | typhlitis | NEUTROPENIC ENTEROCOLITIS | ONCOLOGY | docetaxel | cancer | LEUKEMIA | chemotherapy | Life Sciences | Human health and pathology
Journal Article
Bulletin du cancer, 05/2019, Volume 106, Issue 5, p. 407
The demographics of oncology residents has changed since 2010 with the increase in the size of promotions. The evolution of the residents' aspirations towards... 
Journal Article
CLINICAL COLORECTAL CANCER, ISSN 1533-0028, 12/2019, Volume 18, Issue 4, pp. E394 - E401
FOLFIRINOX (leucovorin, 5-fluorouracil, irinotecan, and oxaliplatin) is an accepted standard in metastatic and locally advanced pancreatic cancer (PC), but... 
TRIAL | Clinical parameters | FOLFIRINOX | Laboratory parameters | Prognosis | THERAPY | Risk categories | ONCOLOGY | DEATHS | GEMCITABINE | Life Sciences
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. 394 - 394
394 Background: FOLFIRINOX achieved a significant step forward in the treatment of mPC. However, patient prognosis remains dismal, and better discrimination of... 
Journal Article
Hepato-Gastro, ISSN 1253-7020, 2014, Volume 21, Issue 2, pp. 134 - 141
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.